Baltic and Eurasia Masterclass in Clinical Oncology

 

Baltic and Eurasia Masterclass in Clinical Oncology
D

Immunotherapy in Advanced NSCLC: PD-L1 Treatment Modalities in Clinical Trials, TMB, & Toxicities

By Baltic and Eurasia Masterclass in Clinical Oncology FEATURING Dragana Jovanovic
By Baltic and Eurasia Masterclass in Clinical Oncology FEATURING Dragana Jovanovic
312 views
August 22, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Lung
22:50

Small Cell Lung Cancer: Disease Overview, Staging and Treatment Appr…

Baltic and Eurasia Masterclass in Clinical Oncology

D. Jovanovic

1.0K views
29:12

Principles of Immunotherapy in Advanced NSCLC: Efficacy, TMB and Com…

Baltic and Eurasia Masterclass in Clinical Oncology

D. Jovanovic

298 views
26:42

Immunotherapy in Advanced NSCLC: PD-L1 Treatment Modalities in Clini…

Baltic and Eurasia Masterclass in Clinical Oncology

D. Jovanovic

312 views
28:27

The Role of Targeted and Chemotherapy in Metastatic NSCLC: TKIs in E…

Baltic and Eurasia Masterclass in Clinical Oncology

S. Tjulandin

304 views
25:48

Radiotherapy in Lung Cancer: PET-CT, Concurrent vs. Sequential chemo…

Baltic and Eurasia Masterclass in Clinical Oncology

P. Van Houtte

111 views